Pathophysiology of the basal ganglia in Parkinson's disease
- PMID: 11052215
- DOI: 10.1016/s1471-1931(00)00028-8
Pathophysiology of the basal ganglia in Parkinson's disease
Abstract
Insight into the organization of the basal ganglia in the normal, parkinsonian and L-dopa-induced dyskinesia states is critical for the development of newer and more effective therapies for Parkinson's disease. We believe that the basal ganglia can no longer be thought of as a unidirectional linear system that transfers information based solely on a firing-rate code. Rather, we propose that the basal ganglia is a highly organized network, with operational characteristics that simulate a non-linear dynamic system.
Similar articles
-
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.Nat Rev Neurosci. 2001 Aug;2(8):577-88. doi: 10.1038/35086062. Nat Rev Neurosci. 2001. PMID: 11484001 Review.
-
PET studies and motor complications in Parkinson's disease.Trends Neurosci. 2000 Oct;23(10 Suppl):S101-8. doi: 10.1016/s1471-1931(00)00016-1. Trends Neurosci. 2000. PMID: 11052227 Review.
-
Continuous dopamine-receptor stimulation in early Parkinson's disease.Trends Neurosci. 2000 Oct;23(10 Suppl):S117-26. doi: 10.1016/s1471-1931(00)00030-6. Trends Neurosci. 2000. PMID: 11052229 Review.
-
Continuous dopamine-receptor stimulation in advanced Parkinson's disease.Trends Neurosci. 2000 Oct;23(10 Suppl):S109-15. doi: 10.1016/s1471-1931(00)00029-x. Trends Neurosci. 2000. PMID: 11052228 Review.
-
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications.Lancet Neurol. 2006 Aug;5(8):677-87. doi: 10.1016/S1474-4422(06)70521-X. Lancet Neurol. 2006. PMID: 16857573 Review.
Cited by
-
The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.J Neurosci. 2016 Sep 21;36(38):9873-87. doi: 10.1523/JNEUROSCI.1318-16.2016. J Neurosci. 2016. PMID: 27656025 Free PMC article.
-
Involvement of KV3.4 Channel in Parkinson's Disease: A Key Player in the Control of Midbrain and Striatum Differential Vulnerability during Disease Progression?Antioxidants (Basel). 2024 Aug 18;13(8):999. doi: 10.3390/antiox13080999. Antioxidants (Basel). 2024. PMID: 39199246 Free PMC article.
-
Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism.J Neuroinflammation. 2015 Jan 14;12:5. doi: 10.1186/s12974-014-0228-x. J Neuroinflammation. 2015. PMID: 25586882 Free PMC article.
-
Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.J Neurosci. 2006 Apr 5;26(14):3875-84. doi: 10.1523/JNEUROSCI.4439-05.2006. J Neurosci. 2006. PMID: 16597742 Free PMC article.
-
Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.Br J Pharmacol. 2010 Sep;161(2):271-87. doi: 10.1111/j.1476-5381.2010.00882.x. Br J Pharmacol. 2010. PMID: 20735415 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical